J&J Shots Paused; German Infection Rate Climbs: Virus Update

(Bloomberg) — Johnson & Johnson’s vaccine distribution was paused in much of the U. S. and Europe pending a review of the development of rare blood clots in several women, marking another setback for the global inoculation campaign.

Germany’s rate of infections climbed further beyond a key threshold, a day after the government approved legislation that mandates tougher restrictions in virus hotspots.

Chancellor Angela Merkel urged lawmakers in parliament to support the legislation, which triggers stricter curbs when the incidence rate climbs above 100.

President Emmanuel Macron will meet on Thursday with ministers to prepare the rules for reopening businesses next month, Elysee Palace announced. Macron said in March that bars and restaurants would be back in business in mid-May with outdoor seating, and that cultural establishments also would reopen.

Key Developments:

  • Global Tracker: Cases pass 137 million; deaths exceed 2.95 million
  • Vaccine Tracker: More than 814 million shots given worldwide
  • Blood Clots, Anaphylaxis and Other Vaccine Fears: QuickTake
  • J&J Blood-Clot Pause Done to Educate Doctors, Seek Other Cases
  • What we know about the impact of Covid-19 on children
  • Which vaccine is best, and other questions answered (Video)

Subscribe to a daily update on the virus from Bloomberg’s Prognosis team here.

Click CVID on the terminal for global data on cases and deaths.

Denmark to Reopen Borders for Some Countries (2:26 p.m. HK)

Denmark will gradually reopen its borders to some countries next month when older Danes are expected to have gotten at least one Covid vaccination shot, the government said.

Denmark will be open to vaccinated citizens from European countries as of May 1. Residents who haven’t gotten a shot but come from European countries with low contamination rates will be able to enter Denmark from May 14.

Travelers must provide a recent negative test and isolate upon arrival, unless they have been vaccinated.

Taiwan to Allow Public to Get Vaccination (2:12 p.m. HK)

Thailand government will initially provide 10,000 doses of Covid-19 vaccines for the public from April 21, according to website statement from Taiwan Centers for Disease Control.

German Incidence Rate Hits Three-Month High (1:37 p.m.

HK)

Germany’s rate of Covid-19 infections climbed further beyond a key threshold, a day after the government approved legislation that mandates tougher restrictions in virus hotspots.

The seven-day rate of cases per 100,000 people rose to 153.2, the most since Jan. 13, the RKI public-health agency said on its website.

Chancellor Angela Merkel urged lawmakers in both houses of parliament to support the legislation, which triggers stricter curbs when the incidence rate climbs above 100.

CanSino Finds No Severe Side Effects (1:29 p.m.

HK)

CanSino Biologics Inc said it hasn’t found any severe side effects related to blood clots after about 1 million vaccinations of its adenovirus vector Covid-19 shots. The Tianjin-based vaccine maker responded to recommendations made from the U. S. Centers for Disease Control and Prevention and Food and Drug Administration to pause the use of Johnson & Johnson’s vaccine, after a rare blood-clotting condition was reported in several people.

Similar side effects were also found with AstraZeneca Plc’s vaccine. Shots developed by Astra, J&J, CanSino and Russia’s Sputnik all use cold-causing adenovirus to carry the genetic sequence of coronavirus to stimulate immune response against Covid-19, though the actual type used varies in each vaccine.

France Prepares to Reopen Businesses (1:28 p.m. HK)

President Emmanuel Macron will meet Thursday with ministers to prepare the rules for reopening French businesses next month, Elysee Palace announced.

Macron said in March that bars and restaurants would be back in business in mid-May with outdoor seating, and that cultural establishments also would reopen.

The country is eyeing a restart even as it prepares to cross the threshold of 100,000 deaths from Covid-19.

The toll stands at 99,480, health authorities said late Tuesday.

Asian Countries Take a Look at J&J Shots (12:28 p.m. HK)

Regulators in New Zealand are slated to decide Thursday on the vaccine, and say they will take the latest information into account. The Philippines was expected to sign with J&J this week, while Thailand approved it for emergency use on March 25. India, facing a mounting outbreak, has said it will fast-track approvals of shots that other countries cleared, including the one from J&J.

South Korea, which granted the company conditional approval last week and has placed the largest order in the region for it, said it will monitor the U.

S. suspension and track the shot’s safety. It isn’t expecting shipments until the third quarter. Japan also said it’s gathering information on J&J’s vaccine.

Indonesia is considering Covid-19 vaccines developed by Johnson & Johnson and some other makers to boost its arsenal and curb infections, according to Health Ministry spokesperson Siti Nadia Tarmizi. There’s no certainty of any deal and no approval process for new procurement has taken place, Tarmizi said in a text message on Wednesday

India Records Daily Record of New Cases (12:25 p.m.

HK)

India reported another record daily tally of Covid-19 cases, adding more than 184,000 overnight to push its total number of infections to more than 13.8 million, second only to the U. S. It’s capital New Delhi also reported a record surge, with 13,500 new cases reported on Tuesday.

It comes as the nation’s crematoriums and burial grounds work overtime to cope with the surging number of deaths and hospitals report being swamped with cases.

The escalating public health crisis highlights just how ill-prepared Prime Minister Narendra Modi’s administration has been to deal with this second wave.

Philippines May Miss Growth Target (11:53 a.m. HK)

The Philippines may miss its target of at least 6.5% economic growth this year after a resurgence of Covid-19 infections forced the capital into a two-week lockdown, Economic Planning Secretary Karl Chua said.

“We were a healthy economy before Covid.

Now, we’re struggling,” Chua said in an interview Tuesday. “We were too risk averse: We shut down a big part of the economy when other countries didn’t need to do that.”

Sinopharm Says No Severe Side Effects on Shots (11:46 a.m. HK)

Two inactivated vaccines developed by Sinopharm’s China National Biotec Group have given given more than 100 million doses so far, the company says on its official WeChat account.

The monthly supply of inactivated shots has reached 100 million doses since April.

Annual production for the two inactivated vaccines will be boosted to 3 billion doses after completion of new facilities.

Jakarta Extends Inoculations to General Public (9:01 a.m. HK)

The Indonesian capital is extending its Covid-19 inoculation drive to the general public by allowing those accompanying the elderly to also receive the shot, according to the provincial government.

The initiative would enable Jakarta achieve its goal of vaccinating over 900,000 people, the government said in a statement.

Each person between 18 and 59 years old would also get the vaccine when accompanying two people aged 60 and above to receive their first dose.

Argentina Reports Daily Record of New Cases (8:00 a.m. HK)

Argentina reported a record 27,001 new Covid-19 cases, hitting a total of 2.58 million, according to the country’s evening report.

It recorded another 217 deaths, reaching a total of 58,174.

Australia Goes to Europe for Vaccine Talks (7:27 a.m.

HK)

Australian Trade Minister Dan Tehan will travel for face-to-face talks with ministerial counterparts in Germany, France and Brussels from Thursday, after the European Union restricted exports of Covid-19 vaccines.

The talks will address “the supply of EU-produced Covid-19 vaccines that Australia has contracted and how we can work with the EU to enhance the global supply of vaccines,” Tehan said in an emailed statement.

Bogota to Impose Lockdown as Cases Rise (7:05 a.m.

HK)

Colombia’s capital will impose quarantines beginning on Friday 12 a.m. to Monday 4 a.m. amid an increase of virus cases, Mayor Claudia Lopez said at a press conference.

The city decreed a “red alert” for its hospital network.

J&J Pauses Shots in Clinical Trials (6:56 a.m. HK)

Johnson & Johnson is pausing the administration of its vaccine in all clinical trials while it updates guidance for investigators and participants.

The decision follows the halt of J&J’s vaccine distribution in much of the U.

S. after six women who got the shot developed a rare and severe form of blood clotting.

Most U. S. states halted distribution of the shot following a recommendation for a pause from the U. S. Centers for Disease Control and Prevention and Food and Drug Administration.

Pfizer Ramps Up Production, CEO Says (4:47 p.m. NY)

Pfizer Inc. Chief Executive Albert Bourla said on Twitter that the company ramped up production and will be able to deliver 10% more doses to the U.

S. by the end of next month than had been previously agreed on.

Moderna Shot 90% Effective After Six Months (4:35 p.m. NY)

Moderna Inc.’s vaccine remained more than 90% effective after six months, according to a new analysis of data from the company’s final-stage trial.

Beginning two weeks after the second dose, the shot was more than 90% effective overall, and more than 95% effective at preventing severe cases, according to a statement.

The company didn’t release further details and said the follow-up results were preliminary as the study is continuing.

WHO Urges Pause in Sale of Live Animals (3:20 p.m. NY)

The World Health Organization on Tuesday urged countries to suspend the sale of wild animals at so-called wet markets as an emergency measure, saying 70% of all emerging infectious diseases in humans have wildlife origins.

The first outbreak of Covid-19 was linked to a wet market in Wuhan, China.

“Although the specific mechanism of SARS-CoV-2 emergence has not been definitively identified, at some point or over time, interactions may have occurred that allowed for cross- and perhaps multiple-species pathogen transmission,” the United Nations agency said in a report.

The WHO acknowledged the central role traditional markets play in providing food and livelihoods for large populations.

However, it said that “banning the sale of the animals can protect people’s health — both those working there and those shopping there.”

Biden Says There Are Enough Doses (2:50 p.m. NY)

Dutch Lockdown Measures Extended (1:45 p.m. NY)

Lockdown measures in the Netherlands will be prolonged until at least April 28 as the number of new Covid-19 cases and hospital admissions continue to strain the country’s health system, Prime Minister Mark Rutte said at a press briefing on Tuesday evening.

If fewer patients are admitted, Rutte’s government announced a plan to reopen Dutch society, with first steps including reopening outdoor seating areas and end to a much-debated night-time curfew.

France Suspends Flights to Brazil (1:25 p.m.

NY)

France suspended all flights to and from Brazil until further notice as concern grows over the spread of the Brazilian variant of the virus.

France, which is under a national lockdown, is struggling to contain the pressure on its health system, with intensive-care unit occupancy remaining on a steady increase in the past few weeks, reaching 117.7% on Tuesday. France recorded 39,113 new infections and 345 new deaths in the past 24 hours.

NYC Rescheduling J&J Appointments (10:40 a.m.

NY)

New York Mayor Bill de Blasio said the city would pause all Johnson & Johnson vaccinations on Tuesday following guidance from U. S. health officials.

The city will reschedule upcoming J&J appointments for residents, who will instead receive vaccines made by Pfizer Inc.-BioNTech SE and Moderna Inc., de Blasio said in a Tuesday briefing. De Blasio, who received the J&J shot himself, said the city has given 234,000 doses of the vaccine and hasn’t seen any reports of blood clots.

Overall, New York has delivered more than 5 million doses as it seeks to fully vaccinate 5 million residents by June.

De Blasio made an appeal to the federal government to reallocate shots from regions with over-capacity. “We have endless need, endless demand,” he said.

J&J to Delay Rollout in Europe (9:22 a.m. NY)

Johnson & Johnson decided to delay the rollout of its Covid-19 vaccine in Europe.

The company is reviewing blood clot cases with European health authorities.

Earlier, U. S. health officials recommended a pause in the use of the vaccine. Six women suffered a type of brain blood clot similar to that reported as a rare side effect to the AstraZeneca Plc vaccine. About 6.8 million people in the U. S. have received the J&J shot.

“This announcement will not have a significant impact on our vaccination plan — Johnson & Johnson vaccine makes up less than 5% of the recorded shots in arms in the U.

S. to date,” White House Covid-19 Response Coordinator Jeff Zients said. The U. S. has enough Pfizer and Moderna vaccines to continue the current pace of vaccinations and meet President Biden’s goal, Zients said in a written statement.

South Africa’s medicines regulator, its health minister and researchers are in talks about whether to pause the rollout of J&J vaccines following the U.

S. recommendation, Business Day reported, citing Glenda Gray, head of the South African Medical Research council.

For more articles like this, please visit us at bloomberg.com

©2021 Bloomberg L. P.